Target intelligence / Profile preview

Bacterial cell membrane and cell wall precursor

Molecular classification
Other (structural precursor, not protein, receptor, enzyme, transporter, etc.)
01

Overview

The bacterial cell wall precursor primarily refers to the intermediates—such as lipid II, a lipid-linked disaccharide-pentapeptide—used in the synthesis of peptidoglycan, an essential polymer composed of alternating N-acetylglucosamine (NAG) and N-acetylmuramic acid (NAM) units cross-linked by short peptide chains[2][4][1][6][7]. These precursors are synthesized in the bacterial cytoplasm, translocated across the membrane, and polymerized by penicillin-binding proteins (PBPs) and other enzymes into the rigid meshwork forming the bacterial cell wall[2][4]. The peptidoglycan layer is crucial for cell shape, rigidity, and protection from osmotic pressure[5][4]. In Gram-negative bacteria, precursors also contribute to the production of the outer membrane and lipopolysaccharide; in Gram-positive bacteria, to teichoic and lipoteichoic acids[1][3][6][7]. Many antibiotics act by targeting these biosynthetic or assembly steps, stopping cell wall formation, and causing bacterial cell death[5][6]. This structure is absent in animal cells, making it a highly selective and validated antimicrobial target[5][4][6].

Other names
Peptidoglycan precursorLipid IICell wall biosynthetic intermediateCell envelope precursor
02

Mechanism of action

Inhibition of peptidoglycan synthesis (e.g., inhibition of transpeptidase or glycosyltransferase enzymes); Inhibition of precursor transport (e.g., blocking Lipid II translocation); Disruption of membrane integrity

03

Biological functions

Structural integrityProtection from osmotic stressDetermination of cell shapeAdhesionAntigenicity
04

Disease associations

Infection
05

Safety considerations

Selectivity: mammalian cells lack peptidoglycan, but off-target effects can occurMicrobiome disturbanceHypersensitivity and allergy (e.g., penicillin)
06

Interacting drugs

β-lactam antibiotics (e.g., penicillins, cephalosporins)

4 more in the full profile.

07

Biomarkers

Peptidoglycan fragmentsCell wall antigen patterns (e.g., teichoic acids, lipopolysaccharide)

Beyond the preview

Go deeper on Bacterial cell membrane and cell wall precursor.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bacterial cell membrane and cell wall precursor.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call